Technology has become a key differentiator across industries and the pharmaceutical industry is no exception. Pharmaceuticals, life sciences and healthcare companies are experiencing a wave of competing challenges. In spite of the growing efforts to engage patients in clinical research and other regulatory activities, pharma companies must recognize this new decision making power of patients and needs a new approach to engage patients in drug development. Although pharma companies depends on innovation, science and R&D, it may seem unreasonable that they lag behind in adapting to new technologies.
Digital healthcare is transforming medicine and revolutionising global health systems. Technology giants and start-ups are already disrupting healthcare in many areas to create a patient centric ecosystem. Thus, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies to be ahead of the game and make most use of the healthcare technologies, resources and tools that integrate with patient’s lifestyle and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases to improve success rates and get new drugs to patients faster.
info@corvusglobalevents.com
+44 (0) 207 096
0786
